Epidemiology and Treatment of Beta Thalassemia Major in China
Overview
Authors
Affiliations
Thalassemia, classified as the main types α- and β-thalassemia, is a single gene disorder resulting from globin chain synthesis impairment through the mutation or deletion of globin genes. The incidence of thalassemia is high worldwide, with high associated mortality. Therefore, treatment is important to improve patient outcomes. This paper reviews the current status of β-thalassemia major in China, including its epidemiology and treatment.
Chen S, Liu Y, Yin X, Lu Q, Du X, Huang R BMC Health Serv Res. 2024; 24(1):1215.
PMID: 39390469 PMC: 11468025. DOI: 10.1186/s12913-024-11547-2.
Chappell M, Breda L, Tricoli L, Guerra A, Jarocha D, Castruccio Castracani C Blood. 2024; 144(15):1633-1645.
PMID: 38949981 PMC: 11487647. DOI: 10.1182/blood.2023023349.
Risk of gout attack not increased in patients with thalassemia: a population-based cohort study.
Chen J, Xu Q, Yang P, Huang J, Cheng-Chung Wei J Sci Rep. 2023; 13(1):2756.
PMID: 36797295 PMC: 9935512. DOI: 10.1038/s41598-023-29709-3.
Spatial and Temporal Expression Characteristics of the Gene Family in Six Different Pig Breeds.
Guo X, Liu Z, Mu Y, Huang L, Li K, Zhang J Genes (Basel). 2022; 13(10).
PMID: 36292707 PMC: 9601290. DOI: 10.3390/genes13101822.
Yu Y, Lu C, Gao Y, Li C, Li D, Wang J Front Pediatr. 2022; 10:894444.
PMID: 35783323 PMC: 9245522. DOI: 10.3389/fped.2022.894444.